National Institutes of Health

Ramona develops advanced microscopy tools designed to enhance cellular-level research by capturing detailed images over vast areas. The company's innovative microscope employs custom control electronics to efficiently process large volumes of image data from multiple micro-cameras, allowing researchers to capture and analyze extensive gigapixel datasets. This capability not only provides a wider field of view but also enables synchronous data capture, allowing for real-time observation of cellular processes. By offering a new perspective on cellular dynamics, Ramona's technology empowers researchers to make more informed decisions quickly and effectively.

Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.

Enspectra Health, based in Mountain View, California, specializes in developing advanced imaging systems for medical applications. The company has created the first hand-held multiphoton imager for human use, enabling real-time imaging of live cellular anatomy beneath the skin. Its innovative device combines reflectance confocal and multiphoton laser scanning microscopy to produce multispectral images that reveal details not visible to the naked eye. This technology aids researchers and dermatologists in examining the structure and function of various tissues, including muscle, tendon, cartilage, and skin, thereby enhancing the diagnosis and treatment of skin conditions, particularly skin cancers. Enspectra Health aims to simplify the evaluation process for physicians and improve patient outcomes through its cutting-edge imaging solutions.

Ramona develops advanced microscopy tools designed to enhance cellular-level research by capturing detailed images over vast areas. The company's innovative microscope employs custom control electronics to efficiently process large volumes of image data from multiple micro-cameras, allowing researchers to capture and analyze extensive gigapixel datasets. This capability not only provides a wider field of view but also enables synchronous data capture, allowing for real-time observation of cellular processes. By offering a new perspective on cellular dynamics, Ramona's technology empowers researchers to make more informed decisions quickly and effectively.

Enspectra Health, based in Mountain View, California, specializes in developing advanced imaging systems for medical applications. The company has created the first hand-held multiphoton imager for human use, enabling real-time imaging of live cellular anatomy beneath the skin. Its innovative device combines reflectance confocal and multiphoton laser scanning microscopy to produce multispectral images that reveal details not visible to the naked eye. This technology aids researchers and dermatologists in examining the structure and function of various tissues, including muscle, tendon, cartilage, and skin, thereby enhancing the diagnosis and treatment of skin conditions, particularly skin cancers. Enspectra Health aims to simplify the evaluation process for physicians and improve patient outcomes through its cutting-edge imaging solutions.

Visikol is a CRO focused on advanced drug discovery that is leading the field of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects. Visikol offers a portfolio of drug discovery services ranging from 2D and 3D cell culture model and assay development to in vitro screening, animal tissue histology and automated image processing. The focus of these services is to transform tissues into images and ultimately into quantitative data sets that can be mined for actionable insights that help our Clients make more informed decisions during the drug discovery process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit our website at visikol.com.

MRIMath specializes in medical imaging technology aimed at improving cancer diagnosis and treatment. The company develops solutions that assist oncologists and surgeons in identifying tumors and assessing treatment responses, thereby enhancing patient outcomes in oncology. MRIMath's innovative approach incorporates an interactive human-AI interface that offers a reliable and cost-effective tool for medical practitioners to monitor brain tumor growth. Beyond its imaging technology, MRIMath also provides hospital care, medical device services, and AI consulting, along with AI-powered software designed to streamline healthcare processes.

Ramona develops advanced microscopy tools designed to enhance cellular-level research by capturing detailed images over vast areas. The company's innovative microscope employs custom control electronics to efficiently process large volumes of image data from multiple micro-cameras, allowing researchers to capture and analyze extensive gigapixel datasets. This capability not only provides a wider field of view but also enables synchronous data capture, allowing for real-time observation of cellular processes. By offering a new perspective on cellular dynamics, Ramona's technology empowers researchers to make more informed decisions quickly and effectively.

Visikol is a CRO focused on advanced drug discovery that is leading the field of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects. Visikol offers a portfolio of drug discovery services ranging from 2D and 3D cell culture model and assay development to in vitro screening, animal tissue histology and automated image processing. The focus of these services is to transform tissues into images and ultimately into quantitative data sets that can be mined for actionable insights that help our Clients make more informed decisions during the drug discovery process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit our website at visikol.com.

Ramona develops advanced microscopy tools designed to enhance cellular-level research by capturing detailed images over vast areas. The company's innovative microscope employs custom control electronics to efficiently process large volumes of image data from multiple micro-cameras, allowing researchers to capture and analyze extensive gigapixel datasets. This capability not only provides a wider field of view but also enables synchronous data capture, allowing for real-time observation of cellular processes. By offering a new perspective on cellular dynamics, Ramona's technology empowers researchers to make more informed decisions quickly and effectively.

VisionQuest Biomedical is a medical device company focused on leveraging artificial intelligence to prevent avoidable blindness. The company's flagship software application, EyeStar, aids in the diagnosis of diabetic retinopathy, while another application, Aspire, is designed to detect malarial retinopathy. Expanding its technological scope, VisionQuest has introduced i-RxTherm, which aims to identify early-stage diabetic diseases beyond ocular conditions. VisionQuest develops innovative image-based technologies to improve healthcare accessibility, particularly in diabetes and eye care, benefiting millions in the United States and globally. Their solutions enhance digital binocular indirect ophthalmoscopy examinations and utilize a neural network for effective analysis of retinal images captured with smartphone-based cameras, facilitating early detection of diabetic peripheral neuropathy and retinopathy of prematurity in various healthcare settings.

Perceptive Navigation LLC is a pre-clinical stage medical device company based in Baltimore, Maryland, focused on developing interventional medical devices for image-guided surgery. Its flagship product, Vu-Path, is an innovative intracorporeal ultrasound device that combines forward-viewing ultrasound imaging with a working portal for the introduction of needles, biopsy instruments, guide wires, and therapeutic delivery. Designed to enhance the safety and efficacy of minimally invasive procedures across various medical specialties, including radiology, cardiology, interventional oncology, and urology, Vu-Path addresses critical limitations of existing imaging techniques, which can be costly, cumbersome, and risky. The device aims to provide accurate and precise access to internal structures, thereby reducing procedural times and enhancing overall patient care. By replacing traditional imaging methods like surface ultrasound, CT, X-Ray, and MRI, Vu-Path is positioned to streamline complex surgical operations while minimizing resource requirements. Perceptive Navigation was incorporated in 2012 and continues to advance its technology to meet the needs of the medical community.

Modulim is a leader in light-based imaging technology focused on tissue and vascular assessment through spatial frequency domain imaging (SFDI). The company has developed the Clarifi Imaging System, which aids clinicians in identifying patients at risk for complications such as diabetic foot ulcers and amputations due to compromised circulation. By enabling timely interventions, this technology plays a crucial role in preserving patients' limbs and lives. Additionally, Modulim's devices are applicable in research, aesthetics, and medicine, providing professionals with transformative tools for the prevention, diagnosis, and treatment of various medical skin conditions.

Ramona develops advanced microscopy tools designed to enhance cellular-level research by capturing detailed images over vast areas. The company's innovative microscope employs custom control electronics to efficiently process large volumes of image data from multiple micro-cameras, allowing researchers to capture and analyze extensive gigapixel datasets. This capability not only provides a wider field of view but also enables synchronous data capture, allowing for real-time observation of cellular processes. By offering a new perspective on cellular dynamics, Ramona's technology empowers researchers to make more informed decisions quickly and effectively.

VisionQuest Biomedical is a medical device company focused on leveraging artificial intelligence to prevent avoidable blindness. The company's flagship software application, EyeStar, aids in the diagnosis of diabetic retinopathy, while another application, Aspire, is designed to detect malarial retinopathy. Expanding its technological scope, VisionQuest has introduced i-RxTherm, which aims to identify early-stage diabetic diseases beyond ocular conditions. VisionQuest develops innovative image-based technologies to improve healthcare accessibility, particularly in diabetes and eye care, benefiting millions in the United States and globally. Their solutions enhance digital binocular indirect ophthalmoscopy examinations and utilize a neural network for effective analysis of retinal images captured with smartphone-based cameras, facilitating early detection of diabetic peripheral neuropathy and retinopathy of prematurity in various healthcare settings.

VisionQuest Biomedical is a medical device company focused on leveraging artificial intelligence to prevent avoidable blindness. The company's flagship software application, EyeStar, aids in the diagnosis of diabetic retinopathy, while another application, Aspire, is designed to detect malarial retinopathy. Expanding its technological scope, VisionQuest has introduced i-RxTherm, which aims to identify early-stage diabetic diseases beyond ocular conditions. VisionQuest develops innovative image-based technologies to improve healthcare accessibility, particularly in diabetes and eye care, benefiting millions in the United States and globally. Their solutions enhance digital binocular indirect ophthalmoscopy examinations and utilize a neural network for effective analysis of retinal images captured with smartphone-based cameras, facilitating early detection of diabetic peripheral neuropathy and retinopathy of prematurity in various healthcare settings.

VisionQuest Biomedical is a medical device company focused on leveraging artificial intelligence to prevent avoidable blindness. The company's flagship software application, EyeStar, aids in the diagnosis of diabetic retinopathy, while another application, Aspire, is designed to detect malarial retinopathy. Expanding its technological scope, VisionQuest has introduced i-RxTherm, which aims to identify early-stage diabetic diseases beyond ocular conditions. VisionQuest develops innovative image-based technologies to improve healthcare accessibility, particularly in diabetes and eye care, benefiting millions in the United States and globally. Their solutions enhance digital binocular indirect ophthalmoscopy examinations and utilize a neural network for effective analysis of retinal images captured with smartphone-based cameras, facilitating early detection of diabetic peripheral neuropathy and retinopathy of prematurity in various healthcare settings.